Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 2CNS 2Sarcoma 1Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Gynecologic 1Dermatologic 1Breast 1

Conditions

Multiple Myeloma 17Neoplasms, Plasma Cell 13Leukemia, Lymphocytic, Chronic, B-Cell 5Lymphoma, Non-Hodgkin 4Lymphoma, Large-Cell, Immunoblastic 4Lymphoma, Large B-Cell, Diffuse 4Lymphoma, Follicular 4Lymphoma, B-Cell, Marginal Zone 4Lymphoma 4Leukemia 4Immunoglobulin Light-chain Amyloidosis 4Burkitt Lymphoma 4Waldenstrom Macroglobulinemia 3Primary Myelofibrosis 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Myeloproliferative Disorders 3Myelodysplastic Syndromes 3Lymphoma, Mantle-Cell 3Leukemia, Myeloid, Chronic-Phase 3Leukemia, Myeloid, Acute 3Leukemia, Myeloid, Accelerated Phase 3Leukemia, Hairy Cell 3Hodgkin Disease 3Blast Crisis 3Thrombocythemia, Essential 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Precancerous Conditions 2Polycythemia Vera 2Monoclonal Gammopathy of Undetermined Significance 2Lymphoma, Large-Cell, Anaplastic 2

Interventions

sargramostim 2liposomal amphotericin B 2Voriconazole 2Therapeutics 2Polymerase Chain Reaction 2Itraconazole 2Flow Cytometry 2Amplified Fragment Length Polymorphism Analysis 2thymoglobulin 1aldesleukin 1Valacyclovir 1Stem Cell Transplantation 1Rituximab 1Ribavirin 1Radiotherapy 1Proteasome Inhibitors 1Prednisone 1Peripheral Blood Stem Cell Transplantation 1Pentetic Acid 1Palivizumab 1Monatide (IMS 3015) 1Minocycline 1Methylprednisolone 1Methotrexate 1Lithium Carbonate 1Lithium 1Lenalidomide 1Interleukin-12 Subunit p35 1Interferon-alpha 1Immunomodulating Agents 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Wilms Tumor × Interferon-alpha × Plasma cell × Clear all
NCT00003408 2013-03-26

Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Cancer

National Cancer Institute (NCI)

Phase 2 Completed
40 enrolled
BreastCNSDermatologicGenitourinaryGynecologicLymphoidMyeloidOther hematologic neoplasmPlasma cellSarcoma

Teratoma, Testicular, Testicular Germ Cell Tumor, Carcinoma, Ovarian Epithelial, Blast Crisis, Breast Neoplasms, Burkitt Lymphoma, Hodgkin Disease, Kidney Neoplasms, Leukemia, Leukemia, Hairy Cell, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Mycosis Fungoides, Myelodysplastic Syndromes, Myeloproliferative Disorders, Wilms Tumor, Neuroblastoma, Ovarian Neoplasms, Recurrence, Sarcoma, Sezary Syndrome, Teratoma, Testicular Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Carcinoma, Embryonal, Seminoma, Endodermal Sinus Tumor, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Gestational Trophoblastic Disease, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Dendritic Cell Sarcoma, Interdigitating, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡